Browsing: Pharmaceuticals

Earlier headline on this:Trump says “will be announcing” large firms that are coming back to the US re Chips, carsMore…

InMed Pharmaceuticals press release (NASDAQ:INM): Q2 GAAP EPS of -$3.64. Revenue of $1.11M (-10.5% Y/Y). As of December 31, 2024,…

High risk warning: Foreign exchange trading carries a high level of risk that may not be suitable for all investors.…

I guess they have probably popped up again then… For the second time in a month this is trying hard…

X4 Pharmaceuticals (NASDAQ:XFOR) and Norgine has announced that they have entered into an exclusive licensing and supply agreement under which…